Monday, November 14, 2011

Photo Exhibit By Colorado Bioscience Awards Keynote Rick Guidotti Opens 11/18 At Santa Fe Arts District VSA Colorado/Access Gallery

Photos by Colorado BioScience Association (CBSA) Awards Dinner Keynote Speaker Rick Guidotti will be on display for the general public beginning November 18 (through December 16) at the VSA Colorado/Access Gallery in Denver's Santa Fe Arts District. The announcement is made by Holli Riebel, CBSA President and CEO, who says: “We are very pleased that everyone in the community will have the opportunity to see Rick's powerful images about genetic difference."

View a video about Rick Guidotti's Positive Exposure and its mission:



http://youtu.be/_-cMu3UA4QE

Link to the Business Wire Release

Link to the Pitch Engine Social Media Newswire

Wednesday, November 9, 2011

Colorado BioScience Association Launches Internship Program With Support of 11 Employers + Area Universities

The CBSA is launching its new Internship Program with the support of 11 founding employers in the Denver area. The announcement is made by Holli Riebel, CBSA President and CEO, who says: “Our education committee has been working diligently with our member companies and universities for the past six months to develop a program that will be valuable to both the student interns and participating companies as we go forward. We will begin intern recruitment immediately through early spring 2012 with the first interns expected to be placed in positions by summer 2012."

Participating employers, at program launch, include:

* Allosource
* Amgen
* Baxa Corporation
* CaridianBCT, Becoming TerumoBCT
* Colorado BioScience Association
* Colorado Institute for Drug, Device and Diagnostic Development (CID4)
* GlobeImmune
* Merck
* Sandhill Scientific
* Sharklet Technologies
* Tolmar

"In addition to these 'founding employers,' we've had interest from yet another six companies. Our team has been very pleased with the positive response from both employers and our universities," Mark Spiecker, President & CEO of Sharklet Technologies and Chair of the CBSA Education Committee, explains. "Now more than ever, there's an extreme need for university students to obtain real world experience, in addition to their time in the classroom."

Link to the Business Wire Release

Link to the Pitch Engine Social Media Release

Thursday, November 3, 2011

Love Wine? Love Cats? Now Indulge Both and Help Cat Care Society!

Just in time for Holiday gifting and gathering: Cat Care Society has partnered with Benefit Wines to raise funds with its new "Cat Care Vineyards" selection of wines:

Love Me Malbec - A medium bodied and soft Malbec will delight with plums, leather and chocolate overtones. With well balanced acidity it provides a juicy and easy drinking wine.

Prowlin' Pinot - Layers of ripe red fruit flavors are among the distinctive features of this elegant varietal. It's fresh on the palate, with a long, lingering finish.

Kitten Kabernet - Rich and ripe this Cabernet features ripe berry aromas and an intensely fruity character. Smooth and well structured, it has soft velvety tannins on the finish.

Cotton Chardonnay - Lively and unoaked, this crisp, medium-bodied wine has lovely straw-yellow hues and aromas of apricots, apples and tropical fruits.

Benny's Select Merlot - This estate grown, handcrafted merlot shows a deep red color with aromas of black pepper and ripe red fruit. Soft and well balanced this merlot displays all the characteristics of the varietal.

SHHH-auvignon Blanc - This crisp, mouth-watering wine captivates with refreshing tropical and citrus fruit flavors, and a clean, well-balanced finish.

All are certified organic and vegan friendly.

Link to learn more and order individual bottles or the Collector's and Sampler packages. A portion of each purchase benefits Cat Care Society - see product descriptions.

Wednesday, October 26, 2011

Award-Winning Fashion Photograher Rick Guidotti To Keynote 2011 Colorado BioScience Awards Celebration

The Colorado BioScience Association (CBSA) Annual Awards Dinner is slated for Thursday, December 8, at the Embassy Suites in Downtown Denver. The event, celebrating the success of the bioscience industry in Colorado and its 2011 standout companies and individuals, will feature a keynote presentation by Rick Guidotti of Positive Exposure in New York. The announcement is made by Holli Riebel, CBSA President and CEO, who says: “CBSA is honored to partner with Positive Exposure in sharing Rick’s important message about genetic difference and dynamic images with our industry community.”

“CBSA is honored to partner with Positive Exposure in sharing Rick’s important message about genetic difference and dynamic images with our industry community.”

While in Denver on December 7th, Guidotti will photograph a select group of children in partnership with the Linda Crnic Institute for Down Syndrome, Mile High Down Syndrome Association, Global Down Syndrome Foundation, and Colorado Children’s Hospital. An exhibit reception will also be held at VSA Colorado/Access Gallery, an inclusive nonprofit organization that engages people with disabilities to access and experience the arts, located at 909 Santa Fe Drive, in the Santa Fe Arts District. The Exhibition will be on display from November 18 – December 16, 2011.

Link to the Business Wire Release

Link to the Pitch Engine Social Media Release

Tuesday, October 25, 2011

Things to do in Denver - 'Cajuns Closet Halloween book sale: a Cat Care Society fundraiser'

Quoting from today's Denver Bucket List posting by Chrissy Morin:

"Cajun’s Closet Thrift Shop - 5707 W. 6th Avenue (on the Frontage Road west of Sheridan).

There will be 'creepy' but safe refreshments and special discounts for those who come in costume. Cajun’s was named Denver Westword’s Best Thrift Store for 2011."

Link to the Denver Bucket List

Saturday, October 22, 2011

Genetic Engineering & Biotechnology News: 'Can the FDA Be a Catalyst for Innovation?'

Quoting Colorado's Dr. Tim Rodell (GlobeImmune) and Holli Riebel (CBSA) from the October 15 GEN:

"The products the FDA regulates represent 20% to 25% of every consumer dollar spent in the U.S., Dr. Hamburg pointed out. 'That’s a gigantic percent of the country’s gross domestic product,' Tim Rodell, M.D., CEO of GlobeImmune (www.globeimmune.com) and a member of the BIO board of directors, said. 'Given the FDA’s importance, it warrants being a cabinet-level agency.'

...Although FDA reviewers typically are trained in scientific research, applying that experience to the regulatory environment is learned on the job. 'That’s a significant deficit for the agency,' Dr. Rodell said. 'There’s no process to train the kinds of people the FDA needs.' Consequently, 'it takes one to two years for new reviewers to get up and running.'

Meanwhile, the FDA, in its determination to do no harm, risks being so cautious that it withholds live-saving therapies. Admittedly, it’s a delicate balance. 'Innovation occurs so quickly that FDA staff can’t keep up with new technology,' observed Holli Riebel, president and CEO of Colorado BioScience.

'Patients are waiting and—sometimes—dying, while amazing drugs aren’t released because of fears about potentially adverse reactions. Science isn’t perfect. We can’t push forward without some risks.'

...BIO also supports a progressive approval pathway so that even before final trials are completed, promising therapeutics could be released and monitored. Dr. Rodell suggested that could be accomplished safely and effectively by designing electronic medical records systems to accommodate retrospective, anonymous analysis of drug safety in real time. Therefore, drug developers could track adverse events associated with the commercial release of particular therapies more accurately than under the current system, which depends upon harried physicians taking the time to voluntarily report adverse events. Dr. Rodell added that the FDA is exploring this already with its pilot Sentinel initiative.

Link to the article at the GEN website

CBSA Pres/CEO Holli Riebel: Denver Business Journal 2011 Power Book Finalist, Technology Division

CBSA Pres/CEO Holli Riebel is a Finalist in the Denver Business Journal's 2011 Power Book/Newsmakers Awards Program.

Riebel was nominated in the Technology & Telecommunications Division. Quoting from the DBJ website: "The Colorado BioScience Association has managed to keep the state’s biotech drug and medical-device industries in the minds of public policy makers and national investors at a time of tight funding. CEO and President Holli Riebel (formerly Holli Baumunk) has maintained support for the industry during her first year leading the organization. CBSA organizes a regional conference that each year attracts investors from biotech hubs on the East and West Coasts, and it’s worked to keep state tax incentives and other support largely intact at a time when state funding has been cut for many other programs."

Learn more at the DBJ website.